In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
A recap of the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and...
A recap from the fifth day of the AACR Annual Meeting 2026, including a plenary on early-onset cancers, clinical...
A recap of the fourth day of the AACR Annual Meeting 2026, including a plenary on AI, the NCI...
A recap from the third day of the AACR Annual Meeting 2026, including the Opening Plenary, Clinical Trial Plenaries,...
A recap from the second day of the AACR Annual Meeting 2026, including the 5K, clinical trials, Discovery Science...
A recap of the first day of the AACR Annual Meeting 2026, including coverage of educational sessions and other...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...